News
CHME
0.030
NaN%
--
Weekly Report: what happened at CHME last week (0908-0912)?
Weekly Report · 09/15/2025 10:26
Weekly Report: what happened at CHME last week (0901-0905)?
Weekly Report · 09/08/2025 10:28
Weekly Report: what happened at CHME last week (0825-0829)?
Weekly Report · 09/01/2025 10:24
Weekly Report: what happened at CHME last week (0818-0822)?
Weekly Report · 08/25/2025 10:31
Weekly Report: what happened at CHME last week (0811-0815)?
Weekly Report · 08/18/2025 10:26
Weekly Report: what happened at CHME last week (0804-0808)?
Weekly Report · 08/11/2025 10:30
Weekly Report: what happened at CHME last week (0728-0801)?
Weekly Report · 08/04/2025 10:33
Weekly Report: what happened at CHME last week (0721-0725)?
Weekly Report · 07/28/2025 10:34
Weekly Report: what happened at CHME last week (0714-0718)?
Weekly Report · 07/21/2025 10:27
Weekly Report: what happened at CHME last week (0707-0711)?
Weekly Report · 07/14/2025 10:33
Weekly Report: what happened at CHME last week (0630-0704)?
Weekly Report · 07/07/2025 10:27
Weekly Report: what happened at CHME last week (0623-0627)?
Weekly Report · 06/30/2025 10:31
Weekly Report: what happened at CHME last week (0616-0620)?
Weekly Report · 06/23/2025 10:27
Weekly Report: what happened at CHME last week (0609-0613)?
Weekly Report · 06/16/2025 10:31
Weekly Report: what happened at CHME last week (0602-0606)?
Weekly Report · 06/09/2025 10:32
Weekly Report: what happened at CHME last week (0526-0530)?
Weekly Report · 06/02/2025 10:37
Weekly Report: what happened at CHME last week (0519-0523)?
Weekly Report · 05/26/2025 10:37
Weekly Report: what happened at CHME last week (0512-0516)?
Weekly Report · 05/19/2025 10:30
More
Webull provides a variety of real-time CHME stock news. You can receive the latest news about China Medicine through multiple platforms. This information may help you make smarter investment decisions.
About CHME
China Medicine Corp is a pharmaceutical company. The Company is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The Company's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The Company also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.